semiglutide vs tirzepatide Semaglutide Tirzepatide: Which GLP-1 Wins for Weight Loss? TrimRX | Semaglutide vs Tirzepatide:

Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes, obesity & metabolism vol

AS FEATURED IN Unlock your results Adjust your height and weight below to see your personalized results Estimated weight loss: -17lbs Your BMI is 29.2, which is higher than 38% of the population

Eli Lilly is also enrolling patients in its own trial, TREASURE-CKD , to see if tirzepatide (marketed under the names Mounjaro for type 2 diabetes and Zepbound for obesity) can treat CKD in people with obesity or type 2 diabetes

Circulation 135 (17), 15771585